Vorasidenib in IDH1/2-mutant low-grade glioma: the grey zone of patient’s selection

Overview of attention for article published in Frontiers in oncology, January 2024

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 6,549 followers.

New research: Vorasidenib in IDH1/2-mutant low-grade glioma: the grey zone of patient’s selection https://t.co/93ZaKr9JQ4 #oncology

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.